Skip to main content Skip to footer
Oncidium Foundation
  • Contact us
  • 
  • 
  • 
  • 
  • 
  • About
    • About the foundation
    • Our ambassadors network
    • Our team
    • Oncidium in the USA
    • Our sponsors & partners
  • Our projects
  • Patient information
    • Cancer Types
    • Clinical Trials
    • Stories of hope
  • Access treatment
    • Find a treatment center
    • Register your hospital
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • Donate
  • Contact us
  • About
    • About the foundation
    • Our ambassadors network
    • Our team
    • Oncidium in the USA
    • Our sponsors & partners
  • Our projects
  • Patient information
    • Cancer Types
    • Clinical Trials
    • Stories of hope
  • Access treatment
    • Find a treatment center
    • Register your hospital
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • Donate

Radiotherapeutics

Lu-177-DOTAGA.Glu.(FAPi)2

Target/Mechanism
Fibroblasts
Carrier/Ligand
FAPi
Radiation Type
beta (β–)
Back
Corporate Sponsors
Institutions & Programs Partners
RLT-Connect Partners
  • About
  • Patient support
  • Access treatment
  • Our ambassadors
  • Radiotheranostics Resources
  • Media
  • RLT-connect
  • Donate
  • Contact
  • 
  • 
  • 
  • 
  • 

© 2026 | Oncidium Foundation

  • Disclaimer
  • Privacy policy
  • Manage cookies
Newsletter
Our Impact Report 2025 is out : Measuring Impact, Driving ChangeRead more
Addressing Barriers to Radioligand Therapy at the European ParliamentRead more
